| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 30.97 | -0.55 (-1.74%) | 29.39 - 39.86 | 821.7 thousand |
Market data as of 3:59PM 05/22/13. Quotes are delayed by at least 15 min.
| Open | 31.42 |
|---|---|
| Previous Close | 31.52 |
| Day's Range | 30.85 - 31.85 |
| Market Cap | 1.8B |
| Avg Volume (10 Day) | 853.3K |
| Price/Earnings (Trailing 12 Mo.) | 38.0x |
| Earnings Per Share (Trailing 12 Mo.) | 0.83 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Pass |
| Consistently increased owner earnings? | Pass |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Thoratec Announces FDA Approval Of HeartMate II® Pocket Controller™
PR Newswire - Friday 05/17/2013 8:00 AM ET
Thoratec Presentation At Bank of America Merrill Lynch 2013 Health Care Conference To Be Webcast
PR Newswire - Tuesday 05/14/2013 9:00 AM ET
Thoratec® Reports First Quarter 2013 Results
PR Newswire - Thursday 05/02/2013 4:02 PM ET
Thoratec Schedules First Quarter Conference Call, Webcast
PR Newswire - Monday 04/22/2013 3:13 PM ET
| THOR | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 7.26% | |
| Net Income Growth (1yr) | -39.37% | |
| Total Debt/Equity | 0.01 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | 2.63% | |
| Price/Sales | 3.74 |
| Company | Last | Change |
|---|---|---|
| Insulet Corp | 28.69 | -3.53% |
| HeartWare International Inc | 92.81 | -2.36% |
| DexCom Inc | 20.36 | -3.64% |
| Haemonetics Corp | 41.30 | -1.22% |
| Hill-Rom Holdings Inc | 35.95 | -3.13% |
Data is delayed by at least 15 min.